HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-AUG-12 4GMC TITLE CRYSTAL STRUCTURE OF HCV NS5B POLYMERASE IN COMPLEX WITH A THUMB TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: NS5B POLYMERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 2420-2989; COMPND 5 SYNONYM: RNA-DIRECTED RNA POLYMERASE; COMPND 6 EC: 2.7.7.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_COMMON: HCV; SOURCE 4 ORGANISM_TAXID: 420174; SOURCE 5 STRAIN: HC-J4; SOURCE 6 GENE: NS5B; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: JM109(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET29B KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.COULOMBE REVDAT 2 13-SEP-23 4GMC 1 REMARK SEQADV REVDAT 1 20-FEB-13 4GMC 0 JRNL AUTH P.L.BEAULIEU,R.COULOMBE,J.GILLARD,C.BROCHU,J.DUAN,M.GARNEAU, JRNL AUTH 2 E.JOLICOEUR,P.KUHN,M.A.POUPART,J.RANCOURT,T.A.STAMMERS, JRNL AUTH 3 B.THAVONEKHAM,G.KUKOLJ JRNL TITL ALLOSTERIC N-ACETAMIDE-INDOLE-6-CARBOXYLIC ACID THUMB POCKET JRNL TITL 2 1 INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE - JRNL TITL 3 ACYLSULFONAMIDES AND ACYLSULFAMIDES AS CARBOXYLIC ACID JRNL TITL 4 REPLACEMENTS JRNL REF CAN.J.CHEM. V. 91 66 2013 JRNL REFN ISSN 0008-4042 JRNL DOI 10.1139/CJC-2012-0319 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 41327 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4127 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8568 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 61 REMARK 3 SOLVENT ATOMS : 63 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.39800 REMARK 3 B22 (A**2) : 2.46400 REMARK 3 B33 (A**2) : 7.93400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.251 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.143 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.882 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.838 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : MSI_CNX_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : MSI_CNX_TOPPAR:DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : MSI_CNX_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : MSI_CNX_TOPPAR:ION.PARAM REMARK 3 PARAMETER FILE 5 : BI.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : MSI_CNX_TOPPAR:PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : MSI_CNX_TOPPAR:DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : MSI_CNX_TOPPAR:WATER.TOP REMARK 3 TOPOLOGY FILE 4 : MSI_CNX_TOPPAR:ION.TOP REMARK 3 TOPOLOGY FILE 5 : BI.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GMC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074363. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41572 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.170 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.56000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 3MWV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES, 21% PEG5000 MME, 400 MM REMARK 280 AMMONIUM SULFATE, 10% GLYCEROL, PH 5.4, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 284K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 52.12000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.66500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.13000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.66500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.12000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.13000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 150 REMARK 465 LYS A 151 REMARK 465 GLY A 152 REMARK 465 GLY A 153 REMARK 465 LEU A 564 REMARK 465 SER A 565 REMARK 465 ARG A 566 REMARK 465 ALA A 567 REMARK 465 ARG A 568 REMARK 465 PRO A 569 REMARK 465 ARG A 570 REMARK 465 HIS A 571 REMARK 465 HIS A 572 REMARK 465 HIS A 573 REMARK 465 HIS A 574 REMARK 465 HIS A 575 REMARK 465 HIS A 576 REMARK 465 GLU B 18 REMARK 465 SER B 19 REMARK 465 LYS B 20 REMARK 465 LEU B 21 REMARK 465 PRO B 22 REMARK 465 ILE B 23 REMARK 465 ASN B 24 REMARK 465 PRO B 25 REMARK 465 LEU B 26 REMARK 465 SER B 27 REMARK 465 ASN B 28 REMARK 465 SER B 29 REMARK 465 LEU B 30 REMARK 465 LEU B 31 REMARK 465 ARG B 32 REMARK 465 HIS B 33 REMARK 465 HIS B 34 REMARK 465 ASN B 35 REMARK 465 PRO B 149 REMARK 465 GLU B 150 REMARK 465 LYS B 151 REMARK 465 GLY B 152 REMARK 465 LEU B 564 REMARK 465 SER B 565 REMARK 465 ARG B 566 REMARK 465 ALA B 567 REMARK 465 ARG B 568 REMARK 465 PRO B 569 REMARK 465 ARG B 570 REMARK 465 HIS B 571 REMARK 465 HIS B 572 REMARK 465 HIS B 573 REMARK 465 HIS B 574 REMARK 465 HIS B 575 REMARK 465 HIS B 576 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY B 516 N - CA - C ANGL. DEV. = -29.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 131 -47.83 -130.53 REMARK 500 LEU A 260 -56.00 -130.03 REMARK 500 SER A 347 50.53 81.44 REMARK 500 ALA A 348 57.90 -146.41 REMARK 500 ALA A 416 -33.53 -38.11 REMARK 500 ILE A 424 -67.16 -104.60 REMARK 500 GLU A 437 60.80 38.40 REMARK 500 ALA A 541 -4.42 -52.04 REMARK 500 TYR A 555 31.27 -141.29 REMARK 500 PRO B 13 -131.91 -76.29 REMARK 500 CYS B 14 -21.26 151.07 REMARK 500 ALA B 16 45.71 99.69 REMARK 500 ASP B 61 -160.41 -126.25 REMARK 500 SER B 113 -64.34 -27.24 REMARK 500 PHE B 193 -5.22 -52.33 REMARK 500 LYS B 212 -75.79 -69.50 REMARK 500 PRO B 214 173.30 -56.00 REMARK 500 MET B 215 128.32 -175.87 REMARK 500 LEU B 260 -60.11 -131.49 REMARK 500 ASP B 310 76.52 30.08 REMARK 500 THR B 329 -60.20 -12.45 REMARK 500 SER B 347 52.86 70.51 REMARK 500 ALA B 348 65.56 -157.34 REMARK 500 LEU B 362 33.16 -87.98 REMARK 500 ALA B 376 -79.92 -44.71 REMARK 500 SER B 377 -55.24 -28.49 REMARK 500 THR B 389 -72.37 -48.28 REMARK 500 ARG B 401 -159.19 -108.65 REMARK 500 THR B 403 -124.54 10.78 REMARK 500 PRO B 404 83.31 12.75 REMARK 500 ASN B 406 -147.07 -61.71 REMARK 500 SER B 407 -89.11 29.88 REMARK 500 ALA B 416 -39.27 -34.51 REMARK 500 ILE B 424 -75.63 -91.92 REMARK 500 HIS B 428 -72.61 -53.09 REMARK 500 LEU B 433 -83.07 -76.71 REMARK 500 GLN B 436 2.30 -154.27 REMARK 500 LEU B 439 -5.86 -56.81 REMARK 500 GLU B 440 -74.53 -96.95 REMARK 500 LYS B 441 111.16 -24.73 REMARK 500 TYR B 452 -135.09 -121.04 REMARK 500 SER B 453 106.31 165.33 REMARK 500 LEU B 469 -85.63 39.80 REMARK 500 SER B 470 -13.45 -45.92 REMARK 500 ALA B 471 7.97 -67.34 REMARK 500 LEU B 497 -32.76 -39.94 REMARK 500 GLN B 514 -120.71 -163.25 REMARK 500 PHE B 526 39.90 -91.89 REMARK 500 THR B 532 -64.64 -93.76 REMARK 500 LYS B 533 -164.74 92.03 REMARK 500 REMARK 500 THIS ENTRY HAS 62 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1BI B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 603 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3MWV RELATED DB: PDB REMARK 900 APO NS5B POLYMERASE REMARK 900 RELATED ID: 3MWW RELATED DB: PDB REMARK 900 NS5B POLYMERASE IN COMPLEX WITH AN INHIBITOR DBREF 4GMC A 1 570 UNP O92972 POLG_HCVJ4 2420 2989 DBREF 4GMC B 1 570 UNP O92972 POLG_HCVJ4 2420 2989 SEQADV 4GMC HIS A 571 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS A 572 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS A 573 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS A 574 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS A 575 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS A 576 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS B 571 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS B 572 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS B 573 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS B 574 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS B 575 UNP O92972 EXPRESSION TAG SEQADV 4GMC HIS B 576 UNP O92972 EXPRESSION TAG SEQRES 1 A 576 SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR PRO SEQRES 2 A 576 CYS ALA ALA GLU GLU SER LYS LEU PRO ILE ASN PRO LEU SEQRES 3 A 576 SER ASN SER LEU LEU ARG HIS HIS ASN MET VAL TYR ALA SEQRES 4 A 576 THR THR SER ARG SER ALA SER LEU ARG GLN LYS LYS VAL SEQRES 5 A 576 THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR ARG SEQRES 6 A 576 ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR VAL SEQRES 7 A 576 LYS ALA LYS LEU LEU SER ILE GLU GLU ALA CYS LYS LEU SEQRES 8 A 576 THR PRO PRO HIS SER ALA LYS SER LYS PHE GLY TYR GLY SEQRES 9 A 576 ALA LYS ASP VAL ARG ASN LEU SER SER ARG ALA VAL ASN SEQRES 10 A 576 HIS ILE ARG SER VAL TRP GLU ASP LEU LEU GLU ASP THR SEQRES 11 A 576 GLU THR PRO ILE ASP THR THR ILE MET ALA LYS SER GLU SEQRES 12 A 576 VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS PRO SEQRES 13 A 576 ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG VAL SEQRES 14 A 576 CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR LEU SEQRES 15 A 576 PRO GLN ALA VAL MET GLY SER SER TYR GLY PHE GLN TYR SEQRES 16 A 576 SER PRO LYS GLN ARG VAL GLU PHE LEU VAL ASN THR TRP SEQRES 17 A 576 LYS SER LYS LYS CYS PRO MET GLY PHE SER TYR ASP THR SEQRES 18 A 576 ARG CYS PHE ASP SER THR VAL THR GLU SER ASP ILE ARG SEQRES 19 A 576 VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA PRO SEQRES 20 A 576 GLU ALA ARG GLN ALA ILE ARG SER LEU THR GLU ARG LEU SEQRES 21 A 576 TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN ASN SEQRES 22 A 576 CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU THR SEQRES 23 A 576 THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS ALA SEQRES 24 A 576 THR ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS THR SEQRES 25 A 576 MET LEU VAL ASN GLY ASP ASP LEU VAL VAL ILE CYS GLU SEQRES 26 A 576 SER ALA GLY THR GLN GLU ASP ALA ALA ALA LEU ARG ALA SEQRES 27 A 576 PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO GLY SEQRES 28 A 576 ASP PRO PRO GLN PRO GLU TYR ASP LEU GLU LEU ILE THR SEQRES 29 A 576 SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA SER SEQRES 30 A 576 GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR THR SEQRES 31 A 576 PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS THR SEQRES 32 A 576 PRO ILE ASN SER TRP LEU GLY ASN ILE ILE MET TYR ALA SEQRES 33 A 576 PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS PHE SEQRES 34 A 576 PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS ALA SEQRES 35 A 576 LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE GLU SEQRES 36 A 576 PRO LEU ASP LEU PRO GLN ILE ILE GLU ARG LEU HIS GLY SEQRES 37 A 576 LEU SER ALA PHE THR LEU HIS SER TYR SER PRO GLY GLU SEQRES 38 A 576 ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY VAL SEQRES 39 A 576 PRO PRO LEU ARG THR TRP ARG HIS ARG ALA ARG SER VAL SEQRES 40 A 576 ARG ALA LYS LEU LEU SER GLN GLY GLY ARG ALA ALA THR SEQRES 41 A 576 CYS GLY ARG TYR LEU PHE ASN TRP ALA VAL ARG THR LYS SEQRES 42 A 576 LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU ASP SEQRES 43 A 576 LEU SER GLY TRP PHE VAL ALA GLY TYR SER GLY GLY ASP SEQRES 44 A 576 ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG HIS HIS SEQRES 45 A 576 HIS HIS HIS HIS SEQRES 1 B 576 SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR PRO SEQRES 2 B 576 CYS ALA ALA GLU GLU SER LYS LEU PRO ILE ASN PRO LEU SEQRES 3 B 576 SER ASN SER LEU LEU ARG HIS HIS ASN MET VAL TYR ALA SEQRES 4 B 576 THR THR SER ARG SER ALA SER LEU ARG GLN LYS LYS VAL SEQRES 5 B 576 THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR ARG SEQRES 6 B 576 ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR VAL SEQRES 7 B 576 LYS ALA LYS LEU LEU SER ILE GLU GLU ALA CYS LYS LEU SEQRES 8 B 576 THR PRO PRO HIS SER ALA LYS SER LYS PHE GLY TYR GLY SEQRES 9 B 576 ALA LYS ASP VAL ARG ASN LEU SER SER ARG ALA VAL ASN SEQRES 10 B 576 HIS ILE ARG SER VAL TRP GLU ASP LEU LEU GLU ASP THR SEQRES 11 B 576 GLU THR PRO ILE ASP THR THR ILE MET ALA LYS SER GLU SEQRES 12 B 576 VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS PRO SEQRES 13 B 576 ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG VAL SEQRES 14 B 576 CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR LEU SEQRES 15 B 576 PRO GLN ALA VAL MET GLY SER SER TYR GLY PHE GLN TYR SEQRES 16 B 576 SER PRO LYS GLN ARG VAL GLU PHE LEU VAL ASN THR TRP SEQRES 17 B 576 LYS SER LYS LYS CYS PRO MET GLY PHE SER TYR ASP THR SEQRES 18 B 576 ARG CYS PHE ASP SER THR VAL THR GLU SER ASP ILE ARG SEQRES 19 B 576 VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA PRO SEQRES 20 B 576 GLU ALA ARG GLN ALA ILE ARG SER LEU THR GLU ARG LEU SEQRES 21 B 576 TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN ASN SEQRES 22 B 576 CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU THR SEQRES 23 B 576 THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS ALA SEQRES 24 B 576 THR ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS THR SEQRES 25 B 576 MET LEU VAL ASN GLY ASP ASP LEU VAL VAL ILE CYS GLU SEQRES 26 B 576 SER ALA GLY THR GLN GLU ASP ALA ALA ALA LEU ARG ALA SEQRES 27 B 576 PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO GLY SEQRES 28 B 576 ASP PRO PRO GLN PRO GLU TYR ASP LEU GLU LEU ILE THR SEQRES 29 B 576 SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA SER SEQRES 30 B 576 GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR THR SEQRES 31 B 576 PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS THR SEQRES 32 B 576 PRO ILE ASN SER TRP LEU GLY ASN ILE ILE MET TYR ALA SEQRES 33 B 576 PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS PHE SEQRES 34 B 576 PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS ALA SEQRES 35 B 576 LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE GLU SEQRES 36 B 576 PRO LEU ASP LEU PRO GLN ILE ILE GLU ARG LEU HIS GLY SEQRES 37 B 576 LEU SER ALA PHE THR LEU HIS SER TYR SER PRO GLY GLU SEQRES 38 B 576 ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY VAL SEQRES 39 B 576 PRO PRO LEU ARG THR TRP ARG HIS ARG ALA ARG SER VAL SEQRES 40 B 576 ARG ALA LYS LEU LEU SER GLN GLY GLY ARG ALA ALA THR SEQRES 41 B 576 CYS GLY ARG TYR LEU PHE ASN TRP ALA VAL ARG THR LYS SEQRES 42 B 576 LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU ASP SEQRES 43 B 576 LEU SER GLY TRP PHE VAL ALA GLY TYR SER GLY GLY ASP SEQRES 44 B 576 ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG HIS HIS SEQRES 45 B 576 HIS HIS HIS HIS HET SO4 A 601 5 HET SO4 A 602 5 HET 1BI B 601 41 HET SO4 B 602 5 HET SO4 B 603 5 HETNAM SO4 SULFATE ION HETNAM 1BI 3-CYCLOHEXYL-2-(FURAN-3-YL)-1-[2-(MORPHOLIN-4-YL)-2- HETNAM 2 1BI OXOETHYL]-N-(PHENYLSULFONYL)-1H-INDOLE-6-CARBOXAMIDE FORMUL 3 SO4 4(O4 S 2-) FORMUL 5 1BI C31 H33 N3 O6 S FORMUL 8 HOH *63(H2 O) HELIX 1 1 ASN A 24 SER A 29 1 6 HELIX 2 2 HIS A 33 ASN A 35 5 3 HELIX 3 3 THR A 41 ARG A 43 5 3 HELIX 4 4 SER A 44 THR A 53 1 10 HELIX 5 5 ASP A 61 SER A 76 1 16 HELIX 6 6 SER A 84 LYS A 90 1 7 HELIX 7 7 GLY A 104 ASN A 110 1 7 HELIX 8 8 SER A 112 ASP A 129 1 18 HELIX 9 9 ASP A 164 GLY A 188 1 25 HELIX 10 10 SER A 189 TYR A 195 5 7 HELIX 11 11 SER A 196 LYS A 211 1 16 HELIX 12 12 CYS A 223 VAL A 228 1 6 HELIX 13 13 THR A 229 GLN A 241 1 13 HELIX 14 14 ALA A 246 LEU A 260 1 15 HELIX 15 15 THR A 286 LYS A 307 1 22 HELIX 16 16 GLY A 328 TYR A 346 1 19 HELIX 17 17 ASP A 359 ILE A 363 5 5 HELIX 18 18 PRO A 388 ARG A 401 1 14 HELIX 19 19 ASN A 406 ALA A 416 1 11 HELIX 20 20 THR A 418 ILE A 424 1 7 HELIX 21 21 ILE A 424 GLN A 436 1 13 HELIX 22 22 GLU A 455 LEU A 457 5 3 HELIX 23 23 ASP A 458 GLY A 468 1 11 HELIX 24 24 LEU A 469 THR A 473 5 5 HELIX 25 25 SER A 478 GLY A 493 1 16 HELIX 26 26 PRO A 496 GLY A 515 1 20 HELIX 27 27 GLY A 515 PHE A 526 1 12 HELIX 28 28 ILE A 539 SER A 543 5 5 HELIX 29 29 SER B 44 THR B 53 1 10 HELIX 30 30 ASP B 61 SER B 76 1 16 HELIX 31 31 SER B 84 LEU B 91 1 8 HELIX 32 32 GLY B 104 ASN B 110 1 7 HELIX 33 33 SER B 112 ASP B 129 1 18 HELIX 34 34 ASP B 164 GLY B 188 1 25 HELIX 35 35 SER B 189 TYR B 195 5 7 HELIX 36 36 SER B 196 LYS B 211 1 16 HELIX 37 37 CYS B 223 VAL B 228 1 6 HELIX 38 38 THR B 229 GLN B 241 1 13 HELIX 39 39 ALA B 246 LEU B 260 1 15 HELIX 40 40 THR B 286 LYS B 307 1 22 HELIX 41 41 GLY B 328 TYR B 346 1 19 HELIX 42 42 ASP B 359 ILE B 363 5 5 HELIX 43 43 PRO B 388 ARG B 401 1 14 HELIX 44 44 SER B 407 ALA B 416 1 10 HELIX 45 45 THR B 418 ILE B 424 1 7 HELIX 46 46 ILE B 424 ALA B 435 1 12 HELIX 47 47 GLU B 455 LEU B 457 5 3 HELIX 48 48 ASP B 458 HIS B 467 1 10 HELIX 49 49 GLY B 468 THR B 473 5 6 HELIX 50 50 SER B 478 GLY B 493 1 16 HELIX 51 51 PRO B 496 SER B 513 1 18 HELIX 52 52 GLY B 516 PHE B 526 1 11 SHEET 1 A 5 TYR A 4 TRP A 6 0 SHEET 2 A 5 ASN A 273 ARG A 277 -1 O TYR A 276 N THR A 5 SHEET 3 A 5 GLY A 264 THR A 267 -1 N GLY A 264 O ARG A 277 SHEET 4 A 5 THR A 136 ALA A 140 1 N ILE A 138 O THR A 267 SHEET 5 A 5 LEU A 159 PHE A 162 -1 O PHE A 162 N THR A 137 SHEET 1 B 2 VAL A 37 ALA A 39 0 SHEET 2 B 2 VAL A 144 CYS A 146 -1 O PHE A 145 N TYR A 38 SHEET 1 C 3 PRO A 214 TYR A 219 0 SHEET 2 C 3 ASP A 319 GLU A 325 -1 O CYS A 324 N MET A 215 SHEET 3 C 3 GLN A 309 ASN A 316 -1 N GLN A 309 O GLU A 325 SHEET 1 D 2 ASN A 369 HIS A 374 0 SHEET 2 D 2 ARG A 380 THR A 385 -1 O VAL A 381 N ALA A 373 SHEET 1 E 2 LEU A 443 ILE A 447 0 SHEET 2 E 2 ALA A 450 ILE A 454 -1 O ILE A 454 N LEU A 443 SHEET 1 F 5 TYR B 4 TRP B 6 0 SHEET 2 F 5 ASN B 273 ARG B 277 -1 O TYR B 276 N THR B 5 SHEET 3 F 5 GLY B 264 THR B 267 -1 N LEU B 266 O CYS B 274 SHEET 4 F 5 THR B 136 ALA B 140 1 N THR B 136 O THR B 267 SHEET 5 F 5 LEU B 159 PHE B 162 -1 O PHE B 162 N THR B 137 SHEET 1 G 2 VAL B 37 ALA B 39 0 SHEET 2 G 2 VAL B 144 CYS B 146 -1 O PHE B 145 N TYR B 38 SHEET 1 H 3 GLY B 216 TYR B 219 0 SHEET 2 H 3 ASP B 319 GLU B 325 -1 O VAL B 322 N PHE B 217 SHEET 3 H 3 GLN B 309 ASN B 316 -1 N ASN B 316 O ASP B 319 SHEET 1 I 2 ASN B 369 SER B 371 0 SHEET 2 I 2 TYR B 383 THR B 385 -1 O THR B 385 N ASN B 369 SHEET 1 J 2 GLN B 446 ILE B 447 0 SHEET 2 J 2 ALA B 450 CYS B 451 -1 O ALA B 450 N ILE B 447 SITE 1 AC1 5 ARG A 48 LYS A 51 ARG A 158 THR A 221 SITE 2 AC1 5 CYS A 223 SITE 1 AC2 4 ASN A 291 GLY A 317 ASP A 318 SER A 556 SITE 1 AC3 8 VAL B 37 ALA B 393 ALA B 396 HIS B 428 SITE 2 AC3 8 LEU B 492 GLY B 493 VAL B 494 ARG B 503 SITE 1 AC4 5 ARG B 48 LYS B 51 ARG B 158 THR B 221 SITE 2 AC4 5 CYS B 223 SITE 1 AC5 6 PHE B 193 SER B 288 ASN B 291 GLY B 317 SITE 2 AC5 6 ASP B 318 SER B 556 CRYST1 104.240 106.260 133.330 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009593 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009411 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007500 0.00000